Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
12 hedge funds and large institutions have $149K invested in Timber Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.
14% less funds holding
Funds holding: 14 → 12 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
72% less capital invested
Capital invested by funds: $540K → $149K (-$391K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$1.67M |
| 2 |
Barclays
London,
United Kingdom
|
+$70K |
| 3 |
Jane Street
New York
|
+$5.27K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$719 |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$719 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$189K |
| 2 |
NFG
Nadler Financial Group
Deerfield,
Illinois
|
-$27K |
| 3 |
VF
Virtu Financial
New York
|
-$14.9K |
| 4 |
Two Sigma Investments
New York
|
-$12K |
| 5 |
Goldman Sachs
New York
|
-$8K |
TMBR Hedge Fund Activity: Q3 2019 in Review
12 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q3 2019, worth a combined $149K — down 72% from $540K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TMBR and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Franklin Resources, adding an estimated $1.67M. The largest seller was Vivo Capital, exiting entirely with an estimated $189K sold.
- 12 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q3 2019, down from 14 in Q2 2019.
- Funds reported $149K of Timber Pharmaceuticals, Inc. stock for Q3 2019, down 72% quarter-over-quarter.
- 3 funds opened new Timber Pharmaceuticals, Inc. positions in Q3 2019 and 5 closed out, a net change of -2 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q3 2019 was Franklin Resources, an estimated $1.67M added.
- The largest Timber Pharmaceuticals, Inc. seller in Q3 2019 was Vivo Capital, an estimated $189K sold.
Based on aggregated 13F filings for Q3 2019.